2321 High response rate and progression free survival with PEGylated recombinant human hyaluronidase added to Nab-Paclitaxel/ Gemcitabine in stage IV previously untreated pancreatic cancer patients with high-HA tumors: Interim results of a randomized Phase 2 study

Authors :: Ping Jiang
Sunil R. Hingorani
Andrew Eugene Hendifar
Walter J. Harris
Andrea J. Bullock
Y. Huang
D. D. Von Hoff
X. Wu
Source :: European Journal of Cancer. 51:S439-S440
Publication Year :: 2015
Publisher :: Elsevier BV, 2015.

Subjects :: Oncology
Response rate (survey)
Cancer Research
medicine.medical_specialty
business.industry
Phases of clinical research
medicine.disease
Gemcitabine
Recombinant Human Hyaluronidase
Internal medicine
Pancreatic cancer
Immunology
medicine
Progression-free survival
business
Stage iv
Nab-paclitaxel
medicine.drug

Full Text Access

Tools